E.g., 11/27/2024
E.g., 11/27/2024

bioMérieux Joins with the Rory Staunton Foundation to Host the First National Forum on Sepsis

15 September, 2014

Event to be held Sept. 17 in Washington D.C. and will feature Sen. Charles E. Schumer (D-NY), Konrad Reinhart, MD, of the Global Sepsis Alliance, Dr. Carl Flatley of the Erin K. Flatley Foundation and Thomas Frieden, MD, Director of the CDC.

Sepsis Awareness Month: Fewer than Half of Americans Have Heard of This Devastating Illness

04 September, 2014

Despite the fact that sepsis affects more than a million Americans each year and kills up to half of them, a new survey published by Sepsis Alliance found that fewer than half of all Americans have ever even heard of the term ‘sepsis.’

CDC Safe Healthcare Blog: A Mother's Account: "If we had known about sepsis, we would have looked for sepsis."

04 September, 2014

Today, on CDC’s Safe Healthcare Blog, Orlaith Staunton, mother of 12-year-old sepsis victim Rory Staunton, shares her family’s tragic story in hopes of preventing other families from suffering at the hands of sepsis.

bioMérieux - First-Half 2014 Results

03 September, 2014

The Board of Directors of bioMérieux, a world leader in the field of in vitro diagnostics, met on September 2 under the chairmanship of Jean-Luc Belingard to approve the consolidated financial statements for the six months ended June 30, 2014. The Statutory Auditors had performed a limited review of the financial statements.

ATCC and bioMérieux Collaborate to Deliver Accurate Identification of Industrial Microorganisms

21 August, 2014

Combined capabilities will enhance the accuracy and range of microbial identification for pharmaceutical, food, veterinary labs.

bioMérieux's TEMPO® (Bacillus Cereus) Assay Gains International Approval for Food Safety Testing

01 August, 2014

AOAC Research Institute validates performance of automated food safety solution

BioFire Diagnostics Initiates Clinical study for the FilmArray® Meningitis/Encephalitis Panel

23 July, 2014

Molecular test will quickly identify infectious causes of meningitis and encephalitis.

bioMérieux -  Second-Quarter 2014 Business Review

17 July, 2014

Solid growth in first-half sales

bioMérieux Breaks Ground on New Production Line at Durham Facility

09 July, 2014

Expansion to help address the global public health threat of sepsis and meet the related demand for microbial detection.

bioMérieux 2013 Annual Report

23 June, 2014

In 2013, bioMérieux celebrated both its 50th anniversary and a remarkable entrepreneurial adventure at the service of public health worldwide.

Pioneering Diagnostics